JACC. CardioOncology 2023 Jun 20
Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: Primer.
Related Questions
Are there other measures, pharmocologic or adjunctive, that can be used or are under investigation to mitigate cardiotoxicity related to chemo- or rad...
New answer by at Phoenix Childrens Medical Group (March 11, 2024)
Although pediatric patients rarely have cardiac co-morbidities at the time of diagnosis, we also monitor and treat high blood pressures carefully and follow echos throughout t...